nominally significantp ≤ 0.05
Of the 512, 142 (27.7%) had been tested by the IMPC and 64 (12.5% of the 512 prioritized genes, 45% of the 142 IMPC-tested genes) had a nominally significant (p ≤ 0.05) alteration of whole-body BMD in knockout/knockdown mice, compared to controls.